27570955|t|Functional Neuroimaging Pilot Study of Borderline Personality Disorder in Adolescents
27570955|a|Borderline personality disorder (BPD) is being increasingly recognized by clinicians working with adolescents, and the reliability and validity of the diagnosis have been established in the adolescent population. Adolescence is known to be a period of high risk for BPD development as most patients identify the onset of their symptoms to be in the adolescent period. As with other mental health disorders, personality disorder, are thought to result from the interaction between biological and environmental factors. Functional neuroimaging studies are reporting an increasing amount of data on abnormal neuronal functions in BPD adult patients. However, no functional neuroimaging studies have been conducted in adolescents with BPD .Objectives This pilot project aims to evaluate the feasibility of a functional magnetic resonance imaging (fMRI) study coupled with clinical and psychological measures in adolescent girls with a diagnosis of BPD. It also aims to identify neuronal regions of interest (ROI) for the study of BPD in adolescent girls .Method Six female adolescents meeting DSM-IV criteria for BPD and 6 female adolescents without psychiatric disorder were recruited. Both groups were evaluated for BPD symptoms, depressive symptoms, impulsivity, affective lability, and other potential psychiatric comorbidities. We used fMRI to compare patterns of regional brain activation between these two groups as they viewed 20 positive, 20 negative and 20 neutral emotion-inducing pictures, which were presented in random order .Results Participants were recruited over a period of 22 months. The protocol was well tolerated by participants. Mean age of the BPD group and control group was 15.8 ± 0.9 years-old and 15.5 ± 1.2 years-old respectively. Psychiatric comorbidity and use of medication was common among participants in the BPD group. This group showed higher impulsivity and affective lability scores. For the fMRI task, BPD patients demonstrated greater differences in activation than controls, when viewing negative pictures compared with neutral pictures, in limbic regions (amygdala and right hippocampus and parahippocampal areas) as well as in the superior frontal gyrus, right precentral gyrus and cerebellum, while control group showed greater activation in left precentral gyrus and right orbitofrontal area. Viewing positive pictures compared with neutral pictures led to increased activation of the left hippocampus and both parahippocampal regions, as well as middle cingulate cortex, superior temporal gyrus and cerebellum in the BPD group. In the control group, positive-scene viewing led to increased activity in the left superior parietal gyrus and right middle / superior temporal gyrus .Conclusion Limbic regions and areas from the prefrontal and orbitofrontal cortex are potential ROI for the study of the neurophysiology of BPD in female adolescents. The larger studies are needed to better understand the neural features found in these young patients.
27570955	0	35	Functional Neuroimaging Pilot Study	T062	C0031928
27570955	39	70	Borderline Personality Disorder	T048	C3825111
27570955	74	85	Adolescents	T100	C0205653
27570955	86	117	Borderline personality disorder	T048	C3825111
27570955	119	122	BPD	T048	C3825111
27570955	160	170	clinicians	T097	C0871685
27570955	184	195	adolescents	T100	C0205653
27570955	205	229	reliability and validity	T080	C0035036
27570955	237	246	diagnosis	T080	C1704338
27570955	276	286	adolescent	T100	C0205653
27570955	287	297	population	T098	C1257890
27570955	299	310	Adolescence	T079	C0001578
27570955	328	334	period	T079	C1948053
27570955	338	347	high risk	T033	C0332167
27570955	352	355	BPD	T048	C3825111
27570955	356	367	development	T169	C1527148
27570955	376	384	patients	T101	C0030705
27570955	398	406	onset of	T080	C0332162
27570955	413	421	symptoms	T184	C1457887
27570955	435	445	adolescent	T100	C0205653
27570955	446	452	period	T079	C1948053
27570955	468	491	mental health disorders	T048	C0004936
27570955	493	513	personality disorder	T048	C0031212
27570955	546	557	interaction	T169	C1704675
27570955	566	576	biological	T123	C0005515
27570955	581	602	environmental factors	T169	C1516998
27570955	604	635	Functional neuroimaging studies	T062	C0242481
27570955	674	678	data	T078	C1511726
27570955	682	690	abnormal	T033	C0205161
27570955	691	709	neuronal functions	T042	C1254358
27570955	713	716	BPD	T048	C3825111
27570955	717	722	adult	T100	C0001675
27570955	723	731	patients	T101	C0030705
27570955	745	776	functional neuroimaging studies	T062	C0242481
27570955	800	811	adolescents	T100	C0205653
27570955	817	820	BPD	T048	C3825111
27570955	838	851	pilot project	T062	C0031928
27570955	860	868	evaluate	T058	C0220825
27570955	890	927	functional magnetic resonance imaging	T060	C0376335
27570955	929	933	fMRI	T060	C0376335
27570955	935	940	study	T062	C2603343
27570955	954	962	clinical	T058	C0947289
27570955	967	989	psychological measures	T058	C1254363
27570955	993	1003	adolescent	T100	C0205653
27570955	1004	1009	girls	T100	C0870604
27570955	1017	1026	diagnosis	T033	C0011900
27570955	1030	1033	BPD	T048	C3825111
27570955	1060	1068	neuronal	T025	C0027882
27570955	1069	1088	regions of interest	T082	C0807727
27570955	1090	1093	ROI	T169	C1704675
27570955	1103	1108	study	T062	C2603343
27570955	1112	1115	BPD	T048	C3825111
27570955	1119	1129	adolescent	T100	C0205653
27570955	1130	1135	girls	T100	C0870604
27570955	1148	1166	female adolescents	T100	C0001588
27570955	1175	1181	DSM-IV	T170	C0220952
27570955	1182	1190	criteria	T078	C0243161
27570955	1195	1198	BPD	T048	C3825111
27570955	1205	1223	female adolescents	T100	C0001588
27570955	1232	1252	psychiatric disorder	T048	C0004936
27570955	1258	1267	recruited	T052	C2949735
27570955	1274	1280	groups	T078	C0441833
27570955	1300	1303	BPD	T048	C3825111
27570955	1304	1312	symptoms	T184	C1457887
27570955	1314	1333	depressive symptoms	T184	C0086132
27570955	1335	1346	impulsivity	T055	C0021125
27570955	1348	1366	affective lability	T048	C0859025
27570955	1388	1413	psychiatric comorbidities	T078	C0009488
27570955	1423	1427	fMRI	T060	C0376335
27570955	1439	1447	patterns	T082	C0449774
27570955	1451	1459	regional	T082	C0205147
27570955	1460	1465	brain	T023	C0006104
27570955	1466	1476	activation	T044	C1148560
27570955	1495	1501	groups	T078	C0441833
27570955	1520	1528	positive	T170	C1704254
27570955	1533	1541	negative	T170	C1704254
27570955	1549	1582	neutral emotion-inducing pictures	T170	C1704254
27570955	1608	1614	random	T080	C0439605
27570955	1615	1620	order	T080	C1705176
27570955	1630	1642	Participants	T098	C0679646
27570955	1648	1657	recruited	T052	C2949735
27570955	1665	1671	period	T079	C1948053
27570955	1678	1684	months	T079	C0439231
27570955	1690	1698	protocol	T061	C0008971
27570955	1721	1733	participants	T098	C0679646
27570955	1735	1739	Mean	T081	C0444504
27570955	1740	1743	age	T032	C0001779
27570955	1751	1754	BPD	T048	C3825111
27570955	1755	1760	group	T078	C0441833
27570955	1765	1778	control group	T096	C0009932
27570955	1794	1803	years-old	T079	C1510829
27570955	1819	1828	years-old	T079	C1510829
27570955	1843	1866	Psychiatric comorbidity	T078	C0009488
27570955	1878	1888	medication	T058	C2081612
27570955	1906	1918	participants	T098	C0679646
27570955	1926	1929	BPD	T048	C3825111
27570955	1930	1935	group	T078	C0441833
27570955	1942	1947	group	T078	C0441833
27570955	1962	1973	impulsivity	T055	C0021125
27570955	1978	1996	affective lability	T048	C0859025
27570955	1997	2003	scores	T081	C0449820
27570955	2013	2017	fMRI	T060	C0376335
27570955	2024	2027	BPD	T048	C3825111
27570955	2028	2036	patients	T101	C0030705
27570955	2058	2069	differences	T080	C1705242
27570955	2073	2083	activation	T044	C1148560
27570955	2089	2097	controls	T096	C0009932
27570955	2112	2129	negative pictures	T170	C1704254
27570955	2144	2160	neutral pictures	T170	C1704254
27570955	2165	2171	limbic	T022	C0023715
27570955	2172	2179	regions	T029	C0005898
27570955	2181	2189	amygdala	T023	C0002708
27570955	2194	2211	right hippocampus	T023	C2327364
27570955	2216	2231	parahippocampal	T023	C0228249
27570955	2232	2237	areas	T082	C0205146
27570955	2257	2279	superior frontal gyrus	T023	C0152296
27570955	2281	2303	right precentral gyrus	T023	C2331927
27570955	2308	2318	cerebellum	T023	C0007765
27570955	2326	2339	control group	T096	C0009932
27570955	2355	2365	activation	T044	C1148560
27570955	2369	2390	left precentral gyrus	T023	C2324765
27570955	2395	2419	right orbitofrontal area	T029	C2949891
27570955	2429	2446	positive pictures	T170	C1704254
27570955	2461	2477	neutral pictures	T170	C1704254
27570955	2495	2505	activation	T044	C1148560
27570955	2513	2529	left hippocampus	T023	C2329590
27570955	2539	2554	parahippocampal	T023	C0228249
27570955	2555	2562	regions	T029	C0005898
27570955	2575	2581	middle	T082	C0444598
27570955	2582	2598	cingulate cortex	T023	C0598179
27570955	2600	2623	superior temporal gyrus	T023	C0152309
27570955	2628	2638	cerebellum	T023	C0007765
27570955	2646	2649	BPD	T048	C3825111
27570955	2650	2655	group	T078	C0441833
27570955	2664	2677	control group	T096	C0009932
27570955	2709	2718	increased	T081	C0205217
27570955	2719	2727	activity	T052	C0441655
27570955	2735	2739	left	T082	C0205091
27570955	2740	2763	superior parietal gyrus	T023	C0152303
27570955	2768	2780	right middle	T023	C2339358
27570955	2783	2806	superior temporal gyrus	T023	C2330566
27570955	2819	2825	Limbic	T022	C0023715
27570955	2826	2833	regions	T029	C0005898
27570955	2838	2843	areas	T082	C0205146
27570955	2853	2863	prefrontal	T023	C0162783
27570955	2868	2888	orbitofrontal cortex	T029	C2331062
27570955	2903	2906	ROI	T169	C1704675
27570955	2928	2943	neurophysiology	T039	C0700630
27570955	2947	2950	BPD	T048	C3825111
27570955	2954	2972	female adolescents	T100	C0001588
27570955	3029	3035	neural	T025	C0027882
27570955	3036	3044	features	T080	C1521970
27570955	3060	3065	young	T079	C0332239
27570955	3066	3074	patients	T101	C0030705